Skip to main content
Log in

Pruritus bei Urtikaria

Pruritus and urticaria

  • Leitthema
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Zusammenfassung

Die Urtikaria repräsentiert eine der häufigsten dermatologischen Erkrankungen, die durch das transiente Auftreten von juckenden Urtikae charakterisiert wird. Die Empfindung des Pruritus wird von Patienten mit chronischer Urtikaria als kribbelnd, brennend oder stechend angegeben. Da die Pruritusattacken und das Auftreten von Urtikae nicht vorhersehbar sind, beeinflusst die Urtikaria die Lebensqualität der Patienten stark. In diesem Überblick fokussieren wir uns auf die klinischen Charakteristika, therapeutischen Optionen sowie neue pathophysiologische Mechanismen wie das T-Zell-Zytokin IL-31 beim Pruritus von Patienten mit chronischer Urtikaria.

Abstract

Urticaria is a frequent dermatological skin disease characterized by the occurrence of transient pruritic wheals. The sensation of pruritus has been described to be stinging, tickling and burning in patients with chronic urticaria. Because of the unpredictable attacks of pruritus and swelling, urticaria strongly affects the quality of life in patients. In this review we focus on clinical characteristics, therapeutic options and new pathophysiological mechanisms including the novel T-cell cytokine IL-31 in pruritus of patients with chronic urticaria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Ikoma A, Steinhoff M, Stander S et al (2006) The neurobiology of itch. Nat Rev Neurosci 7(7):535–547

    Article  CAS  PubMed  Google Scholar 

  2. Stander S, Schmelz M (2006) Chronic itch and pain – similarities and differences. Eur J Pain 10(5):473–478

    Article  PubMed  Google Scholar 

  3. Frey M v. (1922) Zur Physiologie der Juckempfindung. Arch Neerl Physiol 7:142–145

    Google Scholar 

  4. Schmelz M, Schmidt R, Bickel A et al (1997) Specific C-receptors for itch in human skin. J Neurosci 17(20):8003–8008

    CAS  PubMed  Google Scholar 

  5. Namer B, Carr R, Johanek LM et al (2008) Separate peripheral pathways for pruritus in man. J Neurophysiol 100(4):2062–2069

    Article  PubMed  Google Scholar 

  6. Raap U, Kapp A (2005) Neuroimmunological findings in allergic skin diseases. Curr Opin Allergy Clin Immunol 5(5):419–424

    Article  CAS  PubMed  Google Scholar 

  7. Raap U, Ikoma A, Kapp A (2006) Neurophysiology of pruritus. Hautarzt 57(5):379–374

    Article  CAS  PubMed  Google Scholar 

  8. Raap U, Ständer S (2010) Pruritus and skin: new insights in the pathomechanism of pruritus. Allergo J 19:58–65

    Google Scholar 

  9. Fuchs R (1900) Hippokrates, sämtliche Werke. H. Lüneburg

  10. Yosipovitch G, Ansari N, Goon A et al (2002) Clinical characteristics of pruritus in chronic idiopathic urticaria. Br J Dermatol 147(1):32–36

    Article  CAS  PubMed  Google Scholar 

  11. O’Donnell BF, Lawlor F, Simpson J et al (1997) The impact of chronic urticaria on the quality of life. Br J Dermatol 136(2):197–201

    Article  Google Scholar 

  12. Zuberbier T, Asero R, Bindslev-Jensen C et al (2009) EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 64(10):1417–1426

    Article  CAS  PubMed  Google Scholar 

  13. Darsow U, Scharein E, Simon D et al (2001) New aspects of itch pathophysiology: component analysis of atopic itch using the „Eppendorf Itch Questionnaire“. Int Arch Allergy Immunol 124(1–3):326–331

    Google Scholar 

  14. Dijkstra D, Leurs R, Chazot P et al (2007) Histamine downregulates monocyte CCL2 production through the histamine H4 receptor. J Allergy Clin Immunol 120(2):300–307

    Article  CAS  PubMed  Google Scholar 

  15. Gutzmer R, Mommert S, Gschwandtner M et al (2009) The histamine H4 receptor is functionally expressed on T(H)2 cells. J Allergy Clin Immunol 123(3):619–625

    Article  CAS  PubMed  Google Scholar 

  16. Rossbach K, Wendorff S, Sander K et al (2009) Histamine H4 receptor antagonism reduces hapten-induced scratching behaviour but not inflammation. Exp Dermatol 18(1):57–63

    Article  CAS  PubMed  Google Scholar 

  17. Groneberg DA, Serowka F, Peckenschneider N et al (2005) Gene expression and regulation of nerve growth factor in atopic dermatitis mast cells and the human mast cell line-1. J Neuroimmunol 161(1–2):87–92

    Google Scholar 

  18. Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science 237(4819):1154–1162

    Article  CAS  PubMed  Google Scholar 

  19. Raap U, Deneka N, Bruder M et al (2008) Differential up-regulation of neurotrophin receptors and functional activity of neurotrophins on peripheral blood eosinophils of patients with allergic rhinitis, atopic dermatitis and nonatopic subjects. Clin Exp Allergy 38(9):1493–1498

    Article  CAS  PubMed  Google Scholar 

  20. Stander S, Weisshaar E, Steinhof M et al (2003) Pruritus – pathophysiology, clinical features and therapy – an overview. J Dtsch Dermatol Ges 1(2):105–118

    Article  PubMed  Google Scholar 

  21. Jorizzo JL, Coutts AA, Eady RA, Greaves MW (1983) Vascular responses of human skin to injection of substance P and mechanism of action. Eur J Pharmacol 87(1):67–76

    Article  CAS  PubMed  Google Scholar 

  22. Hakim-Rad K, Metz M, Maurer M (2009) Mast cells: makers and breakers of allergic inflammation. Curr Opin Allergy Clin Immunol 9(5):427–430

    Article  CAS  PubMed  Google Scholar 

  23. Caproni M, Giomi B, Melani L et al (2006) Cellular infiltrate and related cytokines, chemokines, chemokine receptors and adhesion molecules in chronic autoimmune urticaria: comparison between spontaneous and autologous serum skin test induced wheal. Int J Immunopathol Pharmacol 19(3):507–515

    CAS  PubMed  Google Scholar 

  24. Kobayashi H, Gleich GJ, Butterfield JH, Kita H (2002) Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli. Blood 99(6):2214–2220

    Article  CAS  PubMed  Google Scholar 

  25. Raap U, Goltz C, Deneka N et al (2005) Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects. J Allergy Clin Immunol 115(6):1268–1275

    Article  CAS  PubMed  Google Scholar 

  26. Solomon A, Aloe L, Pe’er J et al (1998) Nerve growth factor is preformed in and activates human peripheral blood eosinophils. J Allergy Clin Immunol 102(3):454–460

    Article  CAS  PubMed  Google Scholar 

  27. Noga O, Englmann C, Hanf G et al (2002) Activation of the specific neurotrophin receptors TrkA, TrkB and TrkC influences the function of eosinophils. Clin Exp Allergy 32(9):1348–1354

    Article  CAS  PubMed  Google Scholar 

  28. Micera A, Vigneti E, Pickholtz D et al (2001) Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci U S A 98(11):6162–6167

    Article  CAS  PubMed  Google Scholar 

  29. Raap U, Werfel T, Goltz C et al (2006) Circulating levels of brain-derived neurotrophic factor correlate with disease severity in the intrinsic type of atopic dermatitis. Allergy 61(12):1416–1418

    Article  CAS  PubMed  Google Scholar 

  30. Dillon SR, Sprecher C, Hammond A et al (2004) Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 5(7):752–760

    Article  CAS  PubMed  Google Scholar 

  31. Raap U, Wieczorek D, Gehring M et al (2010) Increased levels of serum IL-31 in chronic spontaneous urticaria. Exp Dermatol 19(5):464–466

    Article  CAS  PubMed  Google Scholar 

  32. Raap U, Wichmann K, Bruder M et al (2008) Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol 122(2):421–423

    Article  CAS  PubMed  Google Scholar 

  33. Sonkoly E, Muller A, Lauerma AI et al (2006) IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 117(2):411–417

    Article  CAS  PubMed  Google Scholar 

  34. Zuberbier T, Asero R, Bindslev-Jensen C et al (2009) EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 64(10):1427–1443

    Article  CAS  PubMed  Google Scholar 

  35. Siebenhaar F, Degener F, Zuberbier T et al (2009) High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol 123(3):672–679

    Article  CAS  PubMed  Google Scholar 

  36. Phan NQ, Bernhard JD, Luger TA, Stander S (2010) Antipruritic treatment with systemic mu-opioid receptor antagonists: a review. J Am Acad Dermatol (im Druck)

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to U. Raap.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raap, U., Kapp, A., Wedi, B. et al. Pruritus bei Urtikaria. Hautarzt 61, 737–742 (2010). https://doi.org/10.1007/s00105-010-1931-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-010-1931-x

Schlüsselwörter

Keywords

Navigation